
Vertex Pharmaceuticals (NASDAQ:VRTX) has outperformed the market over the past 10 years by 4.83% on an annualized basis producing an average annual return of 16.83%. Currently, Vertex Pharmaceuticals has a market capitalization of $68.84 billion.
Buying $100 In VRTX: If an investor had bought $100 of VRTX stock 10 years ago, it would be worth $464.90 today based on a price of $269.16 for VRTX at the time of writing.
Vertex Pharmaceuticals's Performance Over Last 10 Years

Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.